Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Test of Eltrombopag Olamine Tablets in Humans Under Fasting State

NCT06768632 is registered in ClinicalTrials.gov with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. as lead sponsor.

NCT NCT06768632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06768632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Test of Eltrombopag Olamine Tablets in Humans Under Fasting State
Lead sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
January 2, 2020
Completion date
December 30, 2023
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thrombocytopenia